Systematic review / meta-analysis / 2024
Bariatric surgery was associated with reduced risk of diabetes, hypertension, and cancer, but also with adverse outcomes such as fracture and suicide.
An umbrella review evaluated 30 systematic reviews of randomized controlled trials and observational studies covering 82 meta-analyzed health outcomes associated with bariatric surgery. Of these, 66 (80%) outcomes were significantly associated with bariatric surgery, including 56 health benefits such as lower new-onset diabetes mellitus (OR = 0.39; 95% CI = 0.19-0.79), hypertension (OR = 0.36; 95% CI = 0.33-0.40), dyslipidemia (OR = 0.33; 95% CI = 0.14-0.81), and cancers (OR = 0.65; 95% CI = 0.53-0.80), alongside reductions in all-cause mortality and death due to cancer, diabetes, and cardiovascular diseases. However, 10 outcomes were adverse, including suicide, fracture, gastroesophageal reflux after sleeve gastrectomy, and neonatal morbidities.
Shows an association, not proof of cause and effect.
- Study type
- Umbrella review and meta-analysis
- Who was studied
- Recipients of bariatric surgery across 30 systematic reviews
- What was measured
- 82 meta-analyzed health outcomes including mortality, chronic diseases, and adverse outcomes
THE PAPER
Association of bariatric surgery with indicated and unintended outcomes: An umbrella review and meta-analysis for risk-benefit assessment.
Kim MS, Kim JY, Song YS, Hong S, Won HH, Kim WJ, Kwon Y, Ha J, Fiedorowicz JG, Solmi M, Shin JI, Park S, Rosenthal RJ. Obes Rev, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.